文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

中国呼吸治疗师在新型冠状病毒肺炎患者救治中的作用

[The role of respiratory therapists in the treatment of coronavirus disease 2019 patients in China].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论调查显示呼吸治疗师深度参与COVID-19呼吸评估、决策与操作,但人力严重短缺(医技占比2.9%、RT与床位比约1:11)。

该研究采用自制问卷,调查全国31个省市区救治COVID-19患者的呼吸治疗师(RT),最终回收8省市22家定点医院40份有效问卷(含武汉7家医院)。RT在医疗团队中占医务人员的2.9%(1.5%,6.7%),与床位比约1:11(1:5,1:26),85.0%为外院调入。97.5%参与制定个体化呼吸治疗策略,全部参与呼吸评估、决策及呼吸功能恶化早期识别;100%积极监测呼吸状态并实施标准化氧疗、预防呼吸机相关肺损伤、规范人工气道管理。但不足50%开展应力应变、跨肺压、PetCO2、呼气末肺容积、电阻抗断层成像等监测。结论认为RT在评估、决策与临床实践中充分发挥专业作用,但人力短缺极为突出。

要点

  • RT在医疗团队中占医务人员的2.9%(1.5%,6.7%),RT与床位比约1:11(1:5,1:26),85.0%为外院调入,提示疫情救治中RT人力配置紧张。
  • 97.5%(39/40)的RT参与制定个体化呼吸治疗策略,全部参与呼吸治疗评估与决策以及呼吸功能恶化的早期识别。
  • 100%(40/40)的RT表示会积极监测患者呼吸状态、增加监测手段与频率、实施标准化氧疗、预防呼吸机相关肺损伤(VALI)、规范人工气道管理。
  • 超过90%的RT主导实施经鼻高流量氧疗(HFNC)、肺保护性机械通气、俯卧位通气、肺康复、气道管理、危重症患者转运等呼吸治疗。
  • 不足50%的RT开展应力应变、跨肺压、呼气末二氧化碳分压(PetCO2)、呼气末肺容积、电阻抗断层成像(EIT)等呼吸功能监测。

适用人群与场景

  • 中国31个省、市、自治区救治COVID-19患者的呼吸治疗师(RT),有效问卷来自8省市22家COVID-19定点医院(含武汉7家医院)的40名RT。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • RT参与制定个体化呼吸治疗策略,并参与呼吸治疗评估、决策及呼吸功能恶化的早期识别。
  • RT积极监测患者呼吸状态,增加监测手段和频率,实施标准化氧疗,预防呼吸机相关肺损伤(VALI),规范人工气道管理。
  • 超过90%的RT主导实施经鼻高流量氧疗(HFNC)、肺保护性机械通气、俯卧位通气、肺康复、气道管理、危重症患者转运等呼吸治疗。
  • 85%的RT开展呼吸治疗相关培训与教育,并为医疗团队制定相关标准操作流程(SOP)。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为自制问卷调查研究;发放问卷126份,回收有效问卷40份,来自8省市22家COVID-19定点医院(含武汉7家医院)的RT。
  • RT在医疗团队中占医务人员的2.9%(1.5%,6.7%),RT工作年限约(6.2±5.4)年,RT与床位比约1:11(1:5,1:26),85.0%(34/40)的RT为外院调入。
  • 97.5%(39/40)的RT参与制定个体化呼吸治疗策略,全部RT参与呼吸治疗评估与决策以及呼吸功能恶化的早期识别。
  • 100%(40/40)的RT表示会积极监测呼吸状态、增加监测手段与频率、实施标准化氧疗、预防VALI、规范人工气道管理;不足50%的RT开展应力应变、跨肺压、PetCO2、呼气末肺容积、EIT等呼吸功能监测。
  • 85%的RT开展呼吸治疗相关培训与教育并制定相关SOP;超过90%的RT主导实施HFNC、肺保护性机械通气、俯卧位通气、肺康复、气道管理、危重症患者转运等呼吸治疗。

证据类型、等级与局限

  • 证据类型为自制问卷调查研究;原文未提及证据等级或推荐强度。
  • 局限:发放126份问卷仅回收40份有效问卷,样本量小;调查对象仅来自8省市22家定点医院,代表性有限;为问卷调查,非干预性研究。

对床旁实践的改变

  • 在COVID-19等传染性呼吸系统疾病救治中,RT可承担呼吸评估、决策、个体化呼吸治疗策略制定及呼吸功能恶化早期识别,并主导HFNC、肺保护性机械通气、俯卧位通气、肺康复、气道管理、危重症转运等呼吸治疗实施。
  • RT人力短缺极为突出(占医务人员2.9%、RT与床位比约1:11、85.0%为外院调入),提示疫情救治需提前规划RT人力调配与支援。
  • 不足50%的RT开展应力应变、跨肺压、PetCO2、呼气末肺容积、EIT等呼吸功能监测,提示这些监测手段在疫情救治中应用有限。
  • 原文未提及适用与不适用人群的明确界定及常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the clinical practice of Chinese respiratory therapists (RTs) participating in the treatment of coronavirus disease 2019 (COVID-19) patients and summarize the experience and role of RTs in the treatment of pandemic infectious diseases.

METHODS: A self-designed questionnaire was used to investigate the RTs who treated COVID-19 patients in 31 provinces, cities and autonomous regions in China. The survey questionnaire included the basic work of RTs, the specific work of the treatment for COVID-19 patients and problems encountered at work.

RESULTS: A total of 126 questionnaires were issued and 40 valid questionnaires were collected from RTs who treated COVID-19 patients at 22 COVID-19 designated hospitals in 8 provinces and municipalities. This included 7 hospitals in Wuhan, the epicenter of the epidemic. In their medical team, RTs accounted for 2.9% (1.5%, 6.7%) of medical staff, the working experience of the RTs was about (6.2±5.4) years, the ratio of RTs to beds was about 1:11 (1:5, 1:26), and 85.0% (34/40) of RTs were transferred from other hospitals. 97.5% (39/40) of RTs were involved in formulating individual respiratory care strategies in their medical teams, and they were all involved in the evaluation of respiratory care and decision-making as well as the early identification of deterioration of respiratory function. All RTs [100% (40/40)] indicated that they would actively monitor patients' respiratory status, increase the means and frequency of the monitoring, implement standardized oxygen therapy, prevent ventilator-associated lung injury (VALI), and standardize the management of artificial airway. However, less than 50% of RTs had carried out stress and strain, transpulmonary pressure, partial pressure of end-tidal carbon dioxide (PetCO2), end-expiratory lung volume, electrical impedance tomography (EIT) and other respiratory function monitoring. 85% of RTs conducted training and education related to respiratory care and formulated relevant standard operating procedures for their medical teams. More than 90% of RTs led the implementation of high-flow nasal cannula oxygen therapy (HFNC), pulmonary protective mechanical ventilation, prone ventilation, pulmonary rehabilitation, airway management, transfer of critical patients, and other respiratory treatment.

CONCLUSIONS: RTs performed their professional role fully in the assessment, decision-making, and clinical practice in the treatment of COVID-19 patients. However, the manpower shortage of RTs is extremely prominent, the practical experience has provided the basis for the future treatment of infectious respiratory diseases and effectively promoted the development of respiratory care in China.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang P, Xue Y, Dong M, et al. [The role of respiratory therapists in the treatment of coronavirus disease 2019 patients in China]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296698. doi:10.3760/cma.j.cn121430-20210318-00400

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。